» Articles » PMID: 1701284

Proliferative Potential of Human Brain Tumours As Assessed by Nucleolar Organizer Regions (AgNORs) and Ki67-immunoreactivity

Overview
Specialty Neurosurgery
Date 1990 Jan 1
PMID 1701284
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Two proliferation markers, silver stained nucleolar organizer regions (AgNOR) and immunoreactivity with Ki-67, were used to assess the proliferative activity in 80 smear preparations from neurosurgically removed intracranial tumours. These included 45 gliomas, 18 meningiomas, 8 metastases and 9 others. We found a remarkably close correlation between the results obtained with both methods. Increasing malignancy, as determined by conventional grading, was paralleled by an increase in the growth fraction and the number of nucleolar organizer regions. Linear regression analysis yielded the following equation: AgNORs/cell = 0.35 x L1 (Ki-67) + 3.24, with a correlation coefficient of rs = 0.53 (Spearman rank correlation test, p less than 0.0001). Thus, both the Ki-67 L1 and the AgNOR technique appear suitable for estimating the proliferative potential in smear preparations of human intracranial neoplasms. The AgNOR technique may be particularly useful for application to stereotaxic biopsies since it can easily be performed on minute tumour samples.

Citing Articles

Genetic and Molecular Approaches to Study Neuronal Migration in the Developing Cerebral Cortex.

Dudok J, Leonards P, Wijnholds J Brain Sci. 2017; 7(5).

PMID: 28475113 PMC: 5447935. DOI: 10.3390/brainsci7050053.


Techniques to assess the proliferative potential of brain tumors.

Quinones-Hinojosa A, Sanai N, Smith J, McDermott M J Neurooncol. 2005; 74(1):19-30.

PMID: 16078103 DOI: 10.1007/s11060-004-5758-0.


MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.

Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G Br J Cancer. 1997; 75(9):1269-78.

PMID: 9155045 PMC: 2228241. DOI: 10.1038/bjc.1997.216.


Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.

Demirtas E, Yilmaz F, Ovul I, Oner K Acta Neurochir (Wien). 1996; 138(12):1456-63.

PMID: 9030354 DOI: 10.1007/BF01411126.


The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index.

Schroder R, Ploner C, Ernestus R Neurosurg Rev. 1993; 16(2):145-50.

PMID: 8345908 DOI: 10.1007/BF00258248.


References
1.
Ostertag C, Volk B, Shibata T, Burger P, Kleihues P . The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours. Acta Neurochir (Wien). 1987; 89(3-4):117-21. DOI: 10.1007/BF01560376. View

2.
Jordan G . At the heart of the nucleolus. Nature. 1987; 329(6139):489-90. DOI: 10.1038/329489a0. View

3.
Burger P, Shibata T, Kleihues P . The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol. 1986; 10(9):611-7. DOI: 10.1097/00000478-198609000-00003. View

4.
Ruschoff J, Plate K, Bittinger A . Application of the AgNOR method to cell imprints. J Pathol. 1989; 158(4):333. DOI: 10.1002/path.1711580411. View

5.
Smetana K, Likovsky Z . Nucleolar silver-stained granules in maturing erythroid and granulocytic cells. Cell Tissue Res. 1984; 237(2):367-70. DOI: 10.1007/BF00217159. View